Evidence Based Medicine on FHIR Implementation Guide
2.0.0-ballot - ballot
Evidence Based Medicine on FHIR Implementation Guide
2.0.0-ballot - ballot
Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
| Active as of 2024-11-01 |
<Citation xmlns="http://hl7.org/fhir">
<id value="179559"/>
<meta>
<versionId value="5"/>
<lastUpdated value="2023-12-02T22:30:09.159Z"/>
<profile
value="http://hl7.org/fhir/uv/ebm/StructureDefinition/dataset-citation"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: Citation 179559</b></p><a name="179559"> </a><a name="hc179559"> </a><a name="179559-en-US"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">version: 5; Last updated: 2023-12-02 22:30:09+0000</p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-dataset-citation.html">DatasetCitation</a></p></div><p><b>url</b>: <a href="Citation-179559.html">Citation DatasetCitation: Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and is Associated with Worse Outcomes</a></p><p><b>identifier</b>: FEvIR Object Identifier/179559, <a href="http://terminology.hl7.org/6.0.2/NamingSystem-uri.html" title="As defined by RFC 3986 (http://www.ietf.org/rfc/rfc3986.txt)(with many schemes defined in many RFCs). For OIDs and UUIDs, use the URN form (urn:oid:(note: lowercase) and urn:uuid:). See http://www.ietf.org/rfc/rfc3001.txt and http://www.ietf.org/rfc/rfc4122.txt
This oid is used as an identifier II.root to indicate the the extension is an absolute URI (technically, an IRI). Typically, this is used for OIDs and GUIDs. Note that when this OID is used with OIDs and GUIDs, the II.extension should start with urn:oid or urn:uuid:
Note that this OID is created to aid with interconversion between CDA and FHIR - FHIR uses urn:ietf:rfc:3986 as equivalent to this OID. URIs as identifiers appear more commonly in FHIR.
This OID may also be used in CD.codeSystem.">Uniform Resource Identifier (URI)</a>/urn:oid:2.16.840.1.113883.4.642.40.44.15.24</p><p><b>version</b>: 2.0.0-ballot</p><p><b>title</b>: DatasetCitation: Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and is Associated with Worse Outcomes</p><p><b>status</b>: Active</p><p><b>date</b>: 2024-11-01 10:20:00+0000</p><p><b>publisher</b>: HL7 International / Clinical Decision Support</p><p><b>contact</b>: HL7 International / Clinical Decision Support: <a href="http://www.hl7.org/Special/committees/dss">http://www.hl7.org/Special/committees/dss</a></p><p><b>description</b>: </p><div><p>This Citation Resource is referenced in an example for the EBMonFHIR Implementation Guide.</p>
</div><p><b>jurisdiction</b>: <span title="Codes:{http://unstats.un.org/unsd/methods/m49/m49.htm 001}">World</span></p><p><b>copyright</b>: </p><div><p>https://creativecommons.org/licenses/by-nc-sa/4.0/</p>
</div><p><b>author</b>: Brian S. Alper: </p><h3>Summaries</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Style</b></td><td><b>Text</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://hl7.org/fhir/citation-summary-style comppub}">Computable Publishing</span></td><td><div><p>Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and is Associated with Worse Outcomes [Dataset]. Contributors: Anish Thomas, Lorinc S. Pongor, Rajesh Kumar, Parth Desai [Authors]. In: database of Genotypes and Phenotypes, Accession Number phs003190.v1.p1. Published October 16, 2023. Available at: https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs003190.v1.p1.</p>
</div></td></tr></table><blockquote><p><b>citedArtifact</b></p><p><b>identifier</b>: dbGaP Study Accession/phs003190.v1.p1</p><h3>Titles</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Language</b></td><td><b>Text</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://hl7.org/fhir/title-type primary}">Primary title</span></td><td><span title="Codes:{urn:ietf:bcp:47 en}">English</span></td><td><div><p>Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and is Associated with Worse Outcomes</p>
</div></td></tr></table><h3>Abstracts</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Language</b></td><td><b>Text</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://fevir.net/resources/CodeSystem/179423 description}">Study Description</span></td><td><span title="Codes:{urn:ietf:bcp:47 en}">English</span></td><td><div><p>Small-cell lung cancer (SCLC) is a very aggressive neuroendocrine lung cancer often associated with oncogenic MYC amplifications, which are known to drive SCLC heterogeneity marked by neuroendocrine (NE) and non-neuroendocrine (non-NE) cell states. The genetic mechanisms of MYC amplification and phenotypic plasticity between cell states is not known. Using data from cell-lines and a few patient-derived samples along with integrated whole-genome sequencing, long-range optical mapping, single-cell DNA sequencing, and fluorescence in situ hybridization, we have attempted to successfully characterize extrachromosomal DNA (ecDNA) as the primary source of MYC amplifications and driver fusions in SCLC.</p>
<p>Study Design:
Cross-Sectional
Study Type:
Observational
Total number of consented subjects: 5</p>
</div></td></tr></table><blockquote><p><b>publicationForm</b></p><h3>PublishedIns</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Identifier</b></td><td><b>Title</b></td><td><b>Publisher</b></td><td><b>PublisherLocation</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://hl7.org/fhir/published-in-type D019991}">Database</span></td><td>Abbreviation/dbGaP</td><td>database of Genotypes and Phenotypes</td><td>NLM</td><td>Bethesda, MD, USA</td></tr></table><p><b>citedMedium</b>: <span title="Codes:{http://hl7.org/fhir/cited-medium internet}">Internet</span></p><p><b>articleDate</b>: 2023-10-16</p><p><b>accessionNumber</b>: phs003190.v1.p1</p><p><b>pageCount</b>: Total number of consented subjects: 5</p><p><b>copyright</b>: </p><div><p>Data access provided by: dbGaP Authorized Access. For publicly available data (public ftp), Connect to the public download site. The site contains release notes and manifests. The site also contains data dictionaries, variable summaries, documents, and truncated analyses, whenever available.</p>
</div></blockquote><blockquote><p><b>webLocation</b></p><p><b>classifier</b>: <span title="Codes:{http://hl7.org/fhir/artifact-url-classifier webpage}">Webpage</span></p><p><b>url</b>: <a href="https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs003190.v1.p1">https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs003190.v1.p1</a></p></blockquote><blockquote><p><b>webLocation</b></p><p><b>classifier</b>: <span title="Codes:{https://fevir.net/resources/CodeSystem/179423 defined-in-text}">public download site</span></p><p><b>url</b>: <a href="https://ftp.ncbi.nlm.nih.gov/dbgap/studies/phs003190/phs003190.v1.p1">https://ftp.ncbi.nlm.nih.gov/dbgap/studies/phs003190/phs003190.v1.p1</a></p></blockquote><blockquote><p><b>classification</b></p><p><b>type</b>: <span title="Codes:{http://hl7.org/fhir/cited-artifact-classification-type knowledge-artifact-type}">Knowledge Artifact Type</span></p><p><b>classifier</b>: <span title="Codes:{http://hl7.org/fhir/citation-artifact-classifier D064886}">Dataset</span></p></blockquote><blockquote><p><b>classification</b></p><p><b>type</b>: <span title="Codes:{https://fevir.net/resources/CodeSystem/179423 study-design}">Study Design</span></p><p><b>classifier</b>: <span title="Codes:{https://fevir.net/resources/CodeSystem/181513 SEVCO:01027}">Cross-Sectional</span>, <span title="Codes:{https://fevir.net/resources/CodeSystem/181513 SEVCO:01002}">Observational Research</span></p></blockquote><blockquote><p><b>classification</b></p><p><b>type</b>: <span title="Codes:{https://fevir.net/resources/CodeSystem/179423 defined-in-text}">Primary Phenotype</span></p><p><b>classifier</b>: <span title="Codes:{https://fevir.net/resources/CodeSystem/179423 defined-in-text}">Small Cell Lung Carcinoma</span></p></blockquote><blockquote><p><b>contributorship</b></p><p><b>complete</b>: true</p><blockquote><p><b>entry</b></p><p><b>contributor</b>: <a href="#hc179559/contributor0">Practitioner Anish Thomas </a></p><p><b>affiliation</b>: Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA</p><p><b>contributionType</b>: <span title="Codes:{https://fevir.net/resources/CodeSystem/179423 principal-investigator}">Principal Investigator</span></p><p><b>role</b>: <span title="Codes:{http://hl7.org/fhir/contributor-role author}">Author/Creator</span></p></blockquote><blockquote><p><b>entry</b></p><p><b>contributor</b>: <a href="#hc179559/contributor1">Practitioner Lorinc S. Pongor </a></p><p><b>affiliation</b>: Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA</p><p><b>contributionType</b>: <span title="Codes:{https://fevir.net/resources/CodeSystem/179423 co-investigator}">Co-Investigator</span></p><p><b>role</b>: <span title="Codes:{http://hl7.org/fhir/contributor-role author}">Author/Creator</span></p></blockquote><blockquote><p><b>entry</b></p><p><b>contributor</b>: <a href="#hc179559/contributor2">Practitioner Rajesh Kumar </a></p><p><b>affiliation</b>: Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA</p><p><b>contributionType</b>: <span title="Codes:{https://fevir.net/resources/CodeSystem/179423 co-investigator}">Co-Investigator</span></p><p><b>role</b>: <span title="Codes:{http://hl7.org/fhir/contributor-role author}">Author/Creator</span></p></blockquote><blockquote><p><b>entry</b></p><p><b>contributor</b>: <a href="#hc179559/contributor3">Practitioner Parth Desai </a></p><p><b>affiliation</b>: Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA</p><p><b>contributionType</b>: <span title="Codes:{https://fevir.net/resources/CodeSystem/179423 co-investigator}">Co-Investigator</span></p><p><b>role</b>: <span title="Codes:{http://hl7.org/fhir/contributor-role author}">Author/Creator</span></p></blockquote></blockquote></blockquote><hr/><blockquote><p class="res-header-id"><b>Generated Narrative: Practitioner #contributor0</b></p><a name="179559/contributor0"> </a><a name="hc179559/contributor0"> </a><a name="179559/contributor0-en-US"> </a><p><b>name</b>: Anish Thomas </p></blockquote><hr/><blockquote><p class="res-header-id"><b>Generated Narrative: Practitioner #contributor1</b></p><a name="179559/contributor1"> </a><a name="hc179559/contributor1"> </a><a name="179559/contributor1-en-US"> </a><p><b>name</b>: Lorinc S. Pongor </p></blockquote><hr/><blockquote><p class="res-header-id"><b>Generated Narrative: Practitioner #contributor2</b></p><a name="179559/contributor2"> </a><a name="hc179559/contributor2"> </a><a name="179559/contributor2-en-US"> </a><p><b>name</b>: Rajesh Kumar </p></blockquote><hr/><blockquote><p class="res-header-id"><b>Generated Narrative: Practitioner #contributor3</b></p><a name="179559/contributor3"> </a><a name="hc179559/contributor3"> </a><a name="179559/contributor3-en-US"> </a><p><b>name</b>: Parth Desai </p></blockquote></div>
</text>
<contained>
<Practitioner>
<id value="contributor0"/>
<name>
<family value="Thomas"/>
<given value="Anish"/>
</name>
</Practitioner>
</contained>
<contained>
<Practitioner>
<id value="contributor1"/>
<name>
<family value="Pongor"/>
<given value="Lorinc S."/>
</name>
</Practitioner>
</contained>
<contained>
<Practitioner>
<id value="contributor2"/>
<name>
<family value="Kumar"/>
<given value="Rajesh"/>
</name>
</Practitioner>
</contained>
<contained>
<Practitioner>
<id value="contributor3"/>
<name>
<family value="Desai"/>
<given value="Parth"/>
</name>
</Practitioner>
</contained>
<url value="https://fevir.net/resources/Citation/179559"/>
<identifier>
<type>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
<code value="ACSN"/>
<display value="Accession ID"/>
</coding>
<text value="FEvIR Object Identifier"/>
</type>
<system value="https://fevir.net"/>
<value value="179559"/>
<assigner>
<display value="Computable Publishing LLC"/>
</assigner>
</identifier>
<identifier>
<system value="urn:ietf:rfc:3986"/>
<value value="urn:oid:2.16.840.1.113883.4.642.40.44.15.24"/>
</identifier>
<version value="2.0.0-ballot"/>
<title
value="DatasetCitation: Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and is Associated with Worse Outcomes"/>
<status value="active"/>
<date value="2024-11-01T10:20:00+00:00"/>
<publisher value="HL7 International / Clinical Decision Support"/>
<contact>
<name value="HL7 International / Clinical Decision Support"/>
<telecom>
<system value="url"/>
<value value="http://www.hl7.org/Special/committees/dss"/>
</telecom>
</contact>
<description
value="This Citation Resource is referenced in an example for the EBMonFHIR Implementation Guide."/>
<jurisdiction>
<coding>
<system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/>
<code value="001"/>
<display value="World"/>
</coding>
</jurisdiction>
<copyright value="https://creativecommons.org/licenses/by-nc-sa/4.0/"/>
<author>
<name value="Brian S. Alper"/>
</author>
<summary>
<style>
<coding>
<system value="http://hl7.org/fhir/citation-summary-style"/>
<code value="comppub"/>
<display value="Computable Publishing"/>
</coding>
</style>
<text
value="Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and is Associated with Worse Outcomes [Dataset]. Contributors: Anish Thomas, Lorinc S. Pongor, Rajesh Kumar, Parth Desai [Authors]. In: database of Genotypes and Phenotypes, Accession Number phs003190.v1.p1. Published October 16, 2023. Available at: https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs003190.v1.p1."/>
</summary>
<citedArtifact>
<identifier>
<type>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
<code value="ACSN"/>
<display value="Accession ID"/>
</coding>
<text value="dbGaP Study Accession"/>
</type>
<value value="phs003190.v1.p1"/>
</identifier>
<title>
<type>
<coding>
<system value="http://hl7.org/fhir/title-type"/>
<code value="primary"/>
<display value="Primary title"/>
</coding>
</type>
<language>
<coding>
<system value="urn:ietf:bcp:47"/>
<code value="en"/>
<display value="English"/>
</coding>
</language>
<text
value="Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and is Associated with Worse Outcomes"/>
</title>
<abstract>
<type>
<coding>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="description"/>
<display value="Description"/>
</coding>
<text value="Study Description"/>
</type>
<language>
<coding>
<system value="urn:ietf:bcp:47"/>
<code value="en"/>
<display value="English"/>
</coding>
</language>
<text
value="Small-cell lung cancer (SCLC) is a very aggressive neuroendocrine lung cancer often associated with oncogenic MYC amplifications, which are known to drive SCLC heterogeneity marked by neuroendocrine (NE) and non-neuroendocrine (non-NE) cell states. The genetic mechanisms of MYC amplification and phenotypic plasticity between cell states is not known. Using data from cell-lines and a few patient-derived samples along with integrated whole-genome sequencing, long-range optical mapping, single-cell DNA sequencing, and fluorescence in situ hybridization, we have attempted to successfully characterize extrachromosomal DNA (ecDNA) as the primary source of MYC amplifications and driver fusions in SCLC.
Study Design:
Cross-Sectional
Study Type:
Observational
Total number of consented subjects: 5"/>
</abstract>
<publicationForm>
<publishedIn>
<type>
<coding>
<system value="http://hl7.org/fhir/published-in-type"/>
<code value="D019991"/>
<display value="Database"/>
</coding>
</type>
<identifier>
<type>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
<code value="XX"/>
<display value="Organization identifier"/>
</coding>
<text value="Abbreviation"/>
</type>
<value value="dbGaP"/>
</identifier>
<title value="database of Genotypes and Phenotypes"/>
<publisher>
<display value="NLM"/>
</publisher>
<publisherLocation value="Bethesda, MD, USA"/>
</publishedIn>
<citedMedium>
<coding>
<system value="http://hl7.org/fhir/cited-medium"/>
<code value="internet"/>
<display value="Internet"/>
</coding>
</citedMedium>
<articleDate value="2023-10-16"/>
<accessionNumber value="phs003190.v1.p1"/>
<pageCount value="Total number of consented subjects: 5"/>
<copyright
value="Data access provided by: dbGaP Authorized Access. For publicly available data (public ftp), Connect to the public download site. The site contains release notes and manifests. The site also contains data dictionaries, variable summaries, documents, and truncated analyses, whenever available."/>
</publicationForm>
<webLocation>
<classifier>
<coding>
<system value="http://hl7.org/fhir/artifact-url-classifier"/>
<code value="webpage"/>
<display value="Webpage"/>
</coding>
</classifier>
<url
value="https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs003190.v1.p1"/>
</webLocation>
<webLocation>
<classifier>
<coding>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="defined-in-text"/>
<display value="Defined in text"/>
</coding>
<text value="public download site"/>
</classifier>
<url
value="https://ftp.ncbi.nlm.nih.gov/dbgap/studies/phs003190/phs003190.v1.p1"/>
</webLocation>
<classification>
<type>
<coding>
<system
value="http://hl7.org/fhir/cited-artifact-classification-type"/>
<code value="knowledge-artifact-type"/>
<display value="Knowledge Artifact Type"/>
</coding>
</type>
<classifier>
<coding>
<system value="http://hl7.org/fhir/citation-artifact-classifier"/>
<code value="D064886"/>
<display value="Dataset"/>
</coding>
</classifier>
</classification>
<classification>
<type>
<coding>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="study-design"/>
<display value="Study Design"/>
</coding>
<text value="Study Design"/>
</type>
<classifier>
<coding>
<system value="https://fevir.net/resources/CodeSystem/181513"/>
<code value="SEVCO:01027"/>
<display value="Cross sectional data collection"/>
</coding>
<text value="Cross-Sectional"/>
</classifier>
<classifier>
<coding>
<system value="https://fevir.net/resources/CodeSystem/181513"/>
<code value="SEVCO:01002"/>
<display value="observational research"/>
</coding>
<text value="Observational Research"/>
</classifier>
</classification>
<classification>
<type>
<coding>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="defined-in-text"/>
<display value="Defined in text"/>
</coding>
<text value="Primary Phenotype"/>
</type>
<classifier>
<coding>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="defined-in-text"/>
<display value="Defined in text"/>
</coding>
<text value="Small Cell Lung Carcinoma"/>
</classifier>
</classification>
<contributorship>
<complete value="true"/>
<entry>
<contributor>
<reference value="#contributor0"/>
<type value="Practitioner"/>
</contributor>
<affiliation>
<display
value="Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA"/>
</affiliation>
<contributionType>
<coding>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="principal-investigator"/>
<display value="Principal Investigator"/>
</coding>
<text value="Principal Investigator"/>
</contributionType>
<role>
<coding>
<system value="http://hl7.org/fhir/contributor-role"/>
<code value="author"/>
<display value="Author/Creator"/>
</coding>
</role>
</entry>
<entry>
<contributor>
<reference value="#contributor1"/>
<type value="Practitioner"/>
</contributor>
<affiliation>
<display
value="Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA"/>
</affiliation>
<contributionType>
<coding>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="co-investigator"/>
<display value="Co-Investigator"/>
</coding>
<text value="Co-Investigator"/>
</contributionType>
<role>
<coding>
<system value="http://hl7.org/fhir/contributor-role"/>
<code value="author"/>
<display value="Author/Creator"/>
</coding>
</role>
</entry>
<entry>
<contributor>
<reference value="#contributor2"/>
<type value="Practitioner"/>
</contributor>
<affiliation>
<display
value="Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA"/>
</affiliation>
<contributionType>
<coding>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="co-investigator"/>
<display value="Co-Investigator"/>
</coding>
<text value="Co-Investigator"/>
</contributionType>
<role>
<coding>
<system value="http://hl7.org/fhir/contributor-role"/>
<code value="author"/>
<display value="Author/Creator"/>
</coding>
</role>
</entry>
<entry>
<contributor>
<reference value="#contributor3"/>
<type value="Practitioner"/>
</contributor>
<affiliation>
<display
value="Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA"/>
</affiliation>
<contributionType>
<coding>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="co-investigator"/>
<display value="Co-Investigator"/>
</coding>
<text value="Co-Investigator"/>
</contributionType>
<role>
<coding>
<system value="http://hl7.org/fhir/contributor-role"/>
<code value="author"/>
<display value="Author/Creator"/>
</coding>
</role>
</entry>
</contributorship>
</citedArtifact>
</Citation>
IG © 2024+ HL7 International / Clinical Decision Support. Package hl7.fhir.uv.ebm#2.0.0-ballot based on FHIR 6.0.0-ballot2. Generated 2024-11-01
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change